Enrollment Completed for Phase 3 Pyruvate Dehydrogenase Complex Deficiency (PDCD) Clinical Trial
According to a story from PR Newswire, the pharmaceutical company Saol Therapeutics has recently announced that it has completed its enrollment goals for its phase 3 clinical trial. This trial…